10/07/2026
One of the hardest parts of psychiatric medication management is that two people can have the same diagnosis, take the same medication, and have completely different experiences with it. One person does great. Another has side effects. Another feels nothing at all.
That is why tools like GeneSight and BrightKaire are so interesting.
GeneSight is a pharmacogenomic test, meaning it looks at certain genes that can affect how your body processes psychiatric medications. Some people metabolize certain medications faster, some slower, and that can matter when we are thinking about medication choice, dosing, side effects, and why a medication may not have worked well in the past.
It does not and should never replace a psychiatric evaluation or tell us, with 100% certainty, “this is the medication that will work.” But it gives us another piece of information that can be really helpful when we are trying to make thoughtful medication decisions.
BrightKaire is a little different. And honestly, the science behind it is pretty incredible.
BrightKaire starts with a blood sample and uses a patient’s own cells to create neurons in a lab. Those patient-derived neurons can then be studied to see how they respond to different antidepressant medications. That information is combined with genetic and clinical data to help guide treatment decisions.
“Why are these tests so important, Ron? And if they are, why haven’t I done them before?”
GeneSight helps us better understand how your genetics may affect the way your body handles medication. BrightKaire gives us additional information about how cells derived from your own biology respond to different antidepressants. Both give us more individualized information than we would have from symptoms alone.
Psychiatry will probably never be as simple as running one test and getting a perfect medication answer. It shouldn’t be. The brain is too complicated for that, and there are a lot of things that influence how someone responds to treatment. But when someone has already tried several medications, struggled with side effects, had only partial improvement, or simply wants to make treatment decisions with as much information as possible, these tools can be incredibly useful. These tests can mean hope.
We are big believers in using every meaningful piece of information available; clinical history, symptoms, past medication response, genetics, and newer tools like functional testing to make treatment feel a little less like guessing and a lot more personalized. Because ultimately? That is what good psychiatric care should be.